Literature DB >> 33602307

Respiratory depression in a neonate born to mother on maximum dose sertraline: a case report.

Greg J Marchand1, Katerina Meassick2,3, Hannah Wolf2, Sophia K Hopewell2, Katelyn Sainz2, Sienna M Anderson2, Kelly Ware2, Janelle Vallejo2, Alexa King2, Stacy Ruther2, Giovanna Brazil2, Kaitlynne Cieminski2, Nicolas Calteux2.   

Abstract

BACKGROUND: Mood and anxiety disorders are common in women of childbearing age, especially during the peripartum period. As more women seek medical management for these conditions, there is an increasing need for studies to better examine the effects of exposure to selective serotonin reuptake inhibitors (SSRIs), and other antidepressants, on newborns at the time of delivery. CASE
PRESENTATION: We report the case of a term Caucasian infant born to a 17-year-old white female taking 100 mg of sertraline daily for depression and anxiety who exhibited respiratory depression and hypoxia after an uncomplicated vaginal delivery. The neonate was treated with the use of continuous positive airway pressure (CPAP) and supplemental oxygen and subsequently the symptoms resolved without complication.
CONCLUSIONS: We present this case with the suspicion of poor neonatal adjustment syndrome as the possible cause of the respiratory depression and hypoxia in this newborn.

Entities:  

Keywords:  Neonatal adjustment syndrome; Neonatal exposure; Perinatal; Sertraline

Mesh:

Substances:

Year:  2021        PMID: 33602307      PMCID: PMC7893725          DOI: 10.1186/s13256-020-02640-1

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  19 in total

Review 1.  The maturing kidney: development and susceptibility.

Authors:  R A Gomez; M L Sequeira Lopez; L Fernandez; D R Cherñavvsky; V F Norwood
Journal:  Ren Fail       Date:  1999 May-Jul       Impact factor: 2.606

2.  Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.

Authors:  Allen A Mitchell; Suzanne M Gilboa; Martha M Werler; Katherine E Kelley; Carol Louik; Sonia Hernández-Díaz
Journal:  Am J Obstet Gynecol       Date:  2011-04-22       Impact factor: 8.661

Review 3.  Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant.

Authors:  Hedvig Nordeng; Olav Spigset
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  The American College of Obstetricians and Gynecologists Committee Opinion no. 630. Screening for perinatal depression.

Authors: 
Journal:  Obstet Gynecol       Date:  2015-05       Impact factor: 7.661

Review 5.  The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis.

Authors:  Sophie Grigoriadis; Emily H VonderPorten; Lana Mamisashvili; Allison Eady; George Tomlinson; Cindy-Lee Dennis; Gideon Koren; Meir Steiner; Patricia Mousmanis; Amy Cheung; Lori E Ross
Journal:  J Clin Psychiatry       Date:  2013-04       Impact factor: 4.384

Review 6.  Glomerular function in neonates.

Authors:  Rozita Hoseini; Hasan Otukesh; Nahid Rahimzadeh; Sara Hoseini
Journal:  Iran J Kidney Dis       Date:  2012-05       Impact factor: 0.892

Review 7.  Pharmacokinetics of selective serotonin reuptake inhibitors.

Authors:  C Hiemke; S Härtter
Journal:  Pharmacol Ther       Date:  2000-01       Impact factor: 12.310

Review 8.  Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.

Authors:  Sura Alwan; Jan M Friedman; Christina Chambers
Journal:  CNS Drugs       Date:  2016-06       Impact factor: 5.749

Review 9.  The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.

Authors:  Kimberly A Yonkers; Katherine L Wisner; Donna E Stewart; Tim F Oberlander; Diana L Dell; Nada Stotland; Susan Ramin; Linda Chaudron; Charles Lockwood
Journal:  Gen Hosp Psychiatry       Date:  2009 Sep-Oct       Impact factor: 3.238

Review 10.  Clinical pharmacokinetics of selective serotonin reuptake inhibitors.

Authors:  J van Harten
Journal:  Clin Pharmacokinet       Date:  1993-03       Impact factor: 6.447

View more
  2 in total

1.  Current research in pathophysiology of opioid-induced respiratory depression, neonatal opioid withdrawal syndrome, and neonatal antidepressant exposure syndrome.

Authors:  Brian A Baldo
Journal:  Curr Res Toxicol       Date:  2022-06-06

2.  Effect of Low and High Doses of Two Selective Serotonin Reuptake Inhibitors on Pregnancy Outcomes and Neonatal Mortality.

Authors:  Rafael R Domingues; Hannah P Fricke; Celeste M Sheftel; Autumn M Bell; Luma C Sartori; Robbie S J Manuel; Chandler J Krajco; Milo C Wiltbank; Laura L Hernandez
Journal:  Toxics       Date:  2022-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.